ArticleScientific reports2026
The effects of LINC00324 on cell proliferation, migration, and invasion via autophagy in melanoma.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cutaneous melanoma is a highly aggressive malignant neoplasm. Increasing evidence has suggested that lncRNAs exerts regulatory effects on melanoma proliferation and metastasis. However, the role of LINC00324 in melanoma remains unclear. A review of existing literature revealed that LINC00324 is highly expressed and exhibits oncogenic functions in most tumors. In our study, LINC00324 was found to show low expression in melanoma tissues and cell lines. Subsequently, we measured cell proliferation, migration, invasion and autophagy-related markers. Additionally, the AKT/mTOR signaling pathway was analyzed via Western blotting. In in vitro studies, we observed that LINC00324 inhibits autophagy through AKT/mTOR signaling pathway. Intriguingly, in vivo experiments demonstrated that increased LINC00324 expression was associated with reduced autophagy and suppressed melanoma growth and lung metastasis via the AMPK/mTOR pathway. Collectively, these findings indicate that LINC00324 is involved in regulating autophagy in melanoma and may serve as a suitable new target for inhibiting melanoma progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.